11.05.2017 • NewsPeopleLanxessChemtura

Stephen Forsyth to Become Chief Integration Officer at Lanxess

Stephen C. Forsyth is to become the new Chief Integration Officer of Lanxess....
Stephen C. Forsyth is to become the new Chief Integration Officer of Lanxess. © Lanxess

German specialty chemicals producer Lanxess has named Stephen C. Forsyth (61) as the future Chief Integration Officer responsible for integrating the Chemtura businesses into the Cologne-based company, effective Jun. 1, 2017. Lanxess acquired the US chemical company in April 2017. The newly created position is limited to one year.

Forsyth has more than 35 years of management experience in the chemical industry. Since 2007 he has acted as EVP and CFO of Chemtura. Prior to that, he worked 27 years for the materials company Hexcel, holding various positions. There, he was appointed CFO in 1996, having previously worked as VP International Operations, heading up the business outside the United States. Forsyth holds an MBA from the London Business School.

Lanxess CEO Matthias Zachert said: “Stephen Forsyth brings exactly the qualities that Lanxess needs for integrating the Chemtura business: he has an excellent knowledge of the new businesses and employees and can also draw on longstanding experience in company transformation processes.”

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.

Photo
19.03.2025 • News

Arkema Launches Acrylic Acid Purification Project

Arkema has announced the launch of its Carat Project at its Carling site in France. This initiative aims to enhance the capabilities and sustainability of the facility, which specializes in producing acrylic monomers and superabsorbent polymers.